Literature DB >> 25755591

Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Radha K Dhiman1, Vivek A Saraswat2, Dominique C Valla3, Yogesh Chawla1, Arunanshu Behera4, Vibha Varma5, Swastik Agarwal1, Ajay Duseja1, Pankaj Puri6, Naveen Kalra7, Chittapuram S Rameshbabu8, Vikram Bhatia9, Malay Sharma10, Manoj Kumar9, Subhash Gupta11, Sunil Taneja11, Leileshwar Kaman4, Showkat A Zargar12, Samiran Nundy5, Shivaram P Singh13, Subrat K Acharya14, Jang B Dilawari15.   

Abstract

Portal cavernoma cholangiopathy (PCC) is defined as abnormalities in the extrahepatic biliary system including the cystic duct and gallbladder with or without abnormalities in the 1st and 2nd generation biliary ducts in a patient with portal cavernoma. Presence of a portal cavernoma, typical cholangiographic changes on endoscopic or magnetic resonance cholangiography and the absence of other causes of these biliary changes like bile duct injury, primary sclerosing cholangitis, cholangiocarcinoma etc are mandatory to arrive a diagnosis. Compression by porto-portal collateral veins involving the paracholedochal and epicholedochal venous plexuses and cholecystic veins and ischemic insult due to deficient portal blood supply or prolonged compression by collaterals bring about biliary changes. While the former are reversible after porto-systemic shunt surgery, the latter are not. Majority of the patients with PCC are asymptomatic and approximately 21% are symptomatic. Symptoms in PCC could be in the form of long standing jaundice due to chronic cholestasis, or biliary pain with or without cholangitis due to biliary stones. Endoscopic retrograde cholangiography has no diagnostic role because it is invasive and is associated with risk of complications, hence it is reserved for therapeutic procedures. Magnetic resonance cholangiography and portovenography is a noninvasive and comprehensive imaging technique, and is the modality of choice for mapping of the biliary and vascular abnormalities in these patients. PCC is a progressive condition and symptoms develop late in the course of portal hypertension only in patients with severe or advanced changes of cholangiopathy. Asymptomatic patients with PCC do not require any treatment. Treatment of symptomatic PCC can be approached in a phased manner, coping first with biliary clearance by nasobiliary or biliary stent placement for acute cholangitis and endoscopic biliary sphincterotomy for biliary stone removal; second, with portal decompression by creating portosystemic shunt; and third, with persistent biliary obstruction by performing second-stage biliary drainage surgery such as hepaticojejunostomy or choledochoduodenostomy. Patients with symptomatic PCC have good prognosis after successful endoscopic biliary drainage and after successful shunt surgery.

Entities:  

Keywords:  CBD, common bile duct; CHD, common hepatic duct; CT, computed tomography; EHPVO, extrahepatic portal venous obstruction; ERC, endoscopic retrograde cholangiography; EUS, endoscopic ultrasound; GRADE, Grading of Recommendations, Assessment, Development and Evaluation; INASL, Indian National Association for Study of the Liver; MRC, magnetic resonance cholangiography; MRI, magnetic resonance imaging; NCPF, non-cirrhotic portal fibrosis; PSS, portosystemic shunt; PVT, portal vein thrombosis; UDCA, ursodeoxycholic acid; USG, ultrasound; cholestasis; extrahepatic portal venous obstruction; gallbladder varices; obstructive jaundice; portal hypertensive biliopathy

Year:  2014        PMID: 25755591      PMCID: PMC4274351          DOI: 10.1016/j.jceh.2014.02.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  75 in total

1.  Portal cholangiopathy: radiological classification and natural history.

Authors:  Elba Llop; Carmen de Juan; Susana Seijo; Angeles García-Criado; Juan G Abraldes; Jaume Bosch; Juan Carlos García-Pagán
Journal:  Gut       Date:  2011-01-26       Impact factor: 23.059

2.  Portal biliopathy treated by liver transplantation.

Authors:  Franco Filipponi; Lucio Urbani; Gabriele Catalano; Giuseppe Iaria; Gianni Biancofiore; Roberto Cioni; Alessandro Campatelli; Franco Mosca; Daniela Campani; Paolo Romagnoli
Journal:  Transplantation       Date:  2004-01-27       Impact factor: 4.939

3.  COMPRESSION OF THE COMMON BILE-DUCT BY AN ENLARGING COLLATERAL VEIN IN A CASE OF PORTAL HYPERTENSION.

Authors:  A H HUNT
Journal:  Br J Surg       Date:  1965-08       Impact factor: 6.939

Review 4.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

5.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

Review 6.  Biliary tract anatomy and its relationship with venous drainage.

Authors:  Chittapuram S Ramesh Babu; Malay Sharma
Journal:  J Clin Exp Hepatol       Date:  2013-05-25

7.  Successful treatment by mesocaval anastomosis of a common-bile-duct compression by choledochal varices.

Authors:  R Arotcarena; D Roulot; A Aubert; P Attali; J Benichou; T Coste
Journal:  J Hepatol       Date:  1995-11       Impact factor: 25.083

8.  Biliary varices on endoscopic ultrasonography: clinical presentation and outcome.

Authors:  L Palazzo; P Hochain; C Helmer; E Cuillerier; B Landi; G Roseau; P H Cugnenc; J P Barbier; C Cellier
Journal:  Endoscopy       Date:  2000-07       Impact factor: 10.093

Review 9.  Portal ductopathy: clinical importance and nomenclature.

Authors:  Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

10.  Hepatic dysfunction in patients with extrahepatic portal venous obstruction.

Authors:  M Rangari; R Gupta; M Jain; V Malhotra; S K Sarin
Journal:  Liver Int       Date:  2003-12       Impact factor: 5.828

View more
  21 in total

Review 1.  Imaging and radiological interventions in extra-hepatic portal vein obstruction.

Authors:  Sudheer S Pargewar; Saloni N Desai; S Rajesh; Vaibhav P Singh; Ankur Arora; Amar Mukund
Journal:  World J Radiol       Date:  2016-06-28

2.  Hepatobiliary quiz-10 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-06

3.  Spectrum of biliary abnormalities in portal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHPVO)-a prospective magnetic resonance cholangiopancreaticography (MRCP) based study.

Authors:  Shumyla Jabeen; Irfan Robbani; Naseer A Choh; Obaid Ashraf; Feroze Shaheen; Tariq Gojwari; Sabeeha Gul
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

4.  2D Shear Wave Elastography of Liver in Patients with Primary Extrahepatic Portal Vein Obstruction.

Authors:  Kumble S Madhusudhan; Raju Sharma; Ragini Kilambi; Sudhin Shylendran; Peush Sahni; Arun K Gupta
Journal:  J Clin Exp Hepatol       Date:  2016-12-29

5.  Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults.

Authors:  Indrani Sen; Lavanya Yohanathan; Jussi M Kärkkäinen; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2020-05-18       Impact factor: 3.452

Review 6.  Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts.

Authors:  Dominique-Charles Valla; Dominique Cazals-Hatem
Journal:  Virchows Arch       Date:  2018-03-24       Impact factor: 4.064

7.  Safety of supramesocolic surgery in patients with portal cavernoma without portal vein decompression. Large single centre experience.

Authors:  Safi Dokmak; Béatrice Aussilhou; Alain Sauvanet; Philippe Lévy; Aurélie Plessier; Fadhel S Ftériche; Olivier Farges; Valérie Vilgrain; Dominique C Valla; Jacques Belghiti
Journal:  HPB (Oxford)       Date:  2016-06-16       Impact factor: 3.647

Review 8.  Evaluation of indeterminate biliary strictures.

Authors:  Christopher L Bowlus; Kristin A Olson; M Eric Gershwin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-11-03       Impact factor: 46.802

9.  Long Term Outcomes of Patients with Significant Biliary Obstruction Due to Portal Cavernoma Cholangiopathy and Extra-Hepatic Portal Vein Obstruction (EHPVO) With No Shuntable Veins.

Authors:  Akash Shukla; Amit Gupte; Vedant Karvir; Prashant Dhore; Shobna Bhatia
Journal:  J Clin Exp Hepatol       Date:  2017-05-19

10.  Portal Cavernoma Cholangiopathy in Children: An Evaluation Using Magnetic Resonance Cholangiography and Endoscopic Ultrasound.

Authors:  Vybhav Venkatesh; Surinder S Rana; Anmol Bhatia; Sadhna B Lal
Journal:  J Clin Exp Hepatol       Date:  2021-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.